Back to Search
OMOTOLA OREDIPE, MD
MD
Internal Medicine Physician
NPI: 1790466175Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
125082766(IL)
Research & Publications (8)
Mice primed with swainsonine are protected against doxorubicin-induced lethality.
PMID 14682391·Cell Mol Biol (Noisy-le-grand)·2003
7-preclinical
Eosinophils in a tri-cell multicellular tumor spheroid (MTS)/endothelium complex.
PMID 14682390·Cell Mol Biol (Noisy-le-grand)·2003
8-other
Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice.
PMID 14682385·Cell Mol Biol (Noisy-le-grand)·2003
7-preclinical
Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.
PMID 14682382·Cell Mol Biol (Noisy-le-grand)·2003
8-other
Inhibition of prostate cancer cell growth by activated eosinophils.
PMID 12949941·Prostate·2003
8-other
Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine.
PMID 12946451·Int Immunopharmacol·2003
7-preclinical
Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
PMID 12639822·Int Immunopharmacol·2003
4-observational
Swainsonine stimulates bone marrow cell proliferation and differentiation in different strains of inbred mice.
PMID 12526864·Pharmacol Res·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1901 W HARRISON ST
CHICAGO, IL 60612 - Phone
- (312) 864-6000
Quick Facts
- NPI
- 1790466175
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile